Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular assist device: can Canada afford this?

M Carrier1

  • 1Montreal Heart Institute, Montreal, Canada. michel.carrier@icm-mhi.org

The Canadian Journal of Cardiology
|November 26, 2005
PubMed
Summary

Heart transplantation is limited by donor shortages. Newer ventricular assist devices offer potential chronic treatment for severe heart failure, moving beyond temporary support.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management.

Research and practice in thrombosis and haemostasis·2024
Same author

Extended-duration thromboprophylaxis following major abdominopelvic surgery - For everyone or selected cases only?

Thrombosis research·2024
Same author

Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting.

Best practice & research. Clinical haematology·2022
Same author

A pilot study investigating the feasibility of using a fully automatic software to assess the RENAL and PADUA score.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

Canadian journal of surgery. Journal canadien de chirurgie·2022

Area of Science:

  • Cardiology
  • Medical Devices
  • Transplantation Medicine

Background:

  • Heart transplantation is a limited treatment for end-stage heart failure due to donor scarcity and high disease incidence.
  • Mechanical circulatory support systems are primarily used for patients at imminent risk of death, bridging them to transplantation.
  • Congestive heart failure affects a significant portion of the Canadian population.

Purpose of the Study:

  • To explore the evolving role of mechanical circulatory support systems in managing end-stage heart failure.
  • To evaluate newer left ventricular assist devices as potential chronic treatment options.
  • To address the limitations of donor availability for heart transplantation.

Main Methods:

  • Review of current mechanical circulatory support systems, focusing on axial and centrifugal flow pumps.
  • Analysis of the transition of these devices from bridge-to-transplantation to potential long-term therapy.
  • Consideration of device advancements in compactness and intelligence.

Main Results:

  • Newer left ventricular assist devices (axial and centrifugal flow pumps) are more advanced and compact.
  • These devices are increasingly considered for chronic treatment of severe congestive heart failure.
  • The limitations of heart transplantation are driving the exploration of alternative long-term solutions.

Conclusions:

  • Advancements in left ventricular assist devices present a promising alternative for chronic heart failure management.
  • Mechanical circulatory support is evolving beyond temporary use to become a viable long-term therapeutic option.
  • Addressing donor shortages necessitates the development and adoption of innovative heart failure treatments.

Related Experiment Videos